AMRX vs. CORT
Compare and contrast key facts about Amneal Pharmaceuticals, Inc. (AMRX) and Corcept Therapeutics Incorporated (CORT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AMRX or CORT.
Correlation
The correlation between AMRX and CORT is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AMRX vs. CORT - Performance Comparison
Key characteristics
AMRX:
0.92
CORT:
1.36
AMRX:
1.69
CORT:
3.88
AMRX:
1.19
CORT:
1.52
AMRX:
0.39
CORT:
3.65
AMRX:
4.01
CORT:
12.82
AMRX:
8.74%
CORT:
12.96%
AMRX:
38.01%
CORT:
121.83%
AMRX:
-97.52%
CORT:
-94.28%
AMRX:
-85.66%
CORT:
-45.51%
Fundamentals
AMRX:
$3.43B
CORT:
$6.57B
AMRX:
-$0.38
CORT:
$1.23
AMRX:
1.23
CORT:
9.73
AMRX:
86.10
CORT:
9.66
AMRX:
$2.13B
CORT:
$528.23M
AMRX:
$782.38M
CORT:
$519.89M
AMRX:
$411.20M
CORT:
$107.91M
Returns By Period
In the year-to-date period, AMRX achieves a -7.07% return, which is significantly lower than CORT's 23.52% return. Over the past 10 years, AMRX has underperformed CORT with an annualized return of -17.50%, while CORT has yielded a comparatively higher 25.55% annualized return.
AMRX
-7.07%
-15.01%
-14.22%
35.79%
18.73%
-17.50%
CORT
23.52%
6.10%
25.11%
171.20%
38.98%
25.55%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AMRX vs. CORT — Risk-Adjusted Performance Rank
AMRX
CORT
AMRX vs. CORT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Amneal Pharmaceuticals, Inc. (AMRX) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AMRX vs. CORT - Dividend Comparison
Neither AMRX nor CORT has paid dividends to shareholders.
Drawdowns
AMRX vs. CORT - Drawdown Comparison
The maximum AMRX drawdown since its inception was -97.52%, roughly equal to the maximum CORT drawdown of -94.28%. Use the drawdown chart below to compare losses from any high point for AMRX and CORT. For additional features, visit the drawdowns tool.
Volatility
AMRX vs. CORT - Volatility Comparison
The current volatility for Amneal Pharmaceuticals, Inc. (AMRX) is 14.81%, while Corcept Therapeutics Incorporated (CORT) has a volatility of 81.19%. This indicates that AMRX experiences smaller price fluctuations and is considered to be less risky than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AMRX vs. CORT - Financials Comparison
This section allows you to compare key financial metrics between Amneal Pharmaceuticals, Inc. and Corcept Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities